Physician profile
Melanie Frederick
NPI 1720062235
$2,983.26
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,690 · 2020: $923 · 2021: $370.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $559.02 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $375.66 | 2019-2021 | |
| Amarin Pharma, INC. | $245.33 | 2019-2020 | |
| Pfizer INC. | $243.07 | 2019-2021 | |
| Novo Nordisk INC | $239.57 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.31 | 2019-2021 | |
| Glaxosmithkline, LLC. | $141.57 | 2019-2020 | |
| Allergan, INC. | $133.60 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $127.92 | 2019-2021 | |
| Lilly USA, LLC | $123.12 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $113.60 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.97 | 2019-2020 | |
| Amgen INC. | $73.39 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $61.90 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $52.68 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $51.32 | 2019 | |
| Daiichi Sankyo INC. | $49.84 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $28.73 | 2019 | |
| Astellas Pharma US INC | $26.60 | 2019-2021 | |
| Abbvie INC. | $26.50 | 2021 | |
| Abbott Laboratories | $17.56 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.